Alligator CD40 agonist
Alligator's CEO comments on the restructuring plan
Alligator Bioscience started the year strong by achieving the primary endpoint of the Phase II OPTIMIZE-1 study with its lead candidate...
Intervju
Video
Alligator's cancer therapy platform granted patent in the US
Through its Neo-X-Prime platform, Alligator Bioscience has developed ATOR-4066...
Intervju
Alligator Bioscience extends orphan drug status to Europe
Regulatory milestones continue to roll in for...
Intervju